z-logo
Premium
P1‐005: DIFFERENT DIAGNOSIS GUIDELINES ON THE ALZHEIMER'S DISEASE CONTINUUM
Author(s) -
Bieger Andrei,
Zimmer Eduardo R.,
Benedet Andrea Lessa,
Pascoal Tharick A.,
Brum Wagner Scheeren,
Souza Diogo O.,
Rosa-Neto Pedro
Publication year - 2019
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2019.06.030
Subject(s) - alzheimer's disease neuroimaging initiative , neuropsychology , medicine , disease , alzheimer's disease , psychiatry , cognition
decreased percentage of resident microglia and increased percentage of infiltrated macrophages were observed when compared with ND-fed rats (p<0.05; Figure 1). In contrast, the level of Ab/ APP and BACE-1 expression was not different between both dietary groups at all time periods. Conclusions: HFD consumption alters gut microbiota prior to metabolic disturbance, leading to brain oxidative stress, synaptic dysplasticity, microglia hyperactivation, and cognitive decline without increasing Alzheimer’s markers in obese-insulin resistant rats. Therefore, the improvement of gut dysbiosis should be a therapeutic target to prevent cognitive decline in obese people.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom